Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04432805

Acronym

LUSCOVIDPREG

Enrollment

Registered

2020-06-16

Start date

2020-10-13

Completion date

2021-01-02

Last updated

2022-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnant Women Suspected of COVID-19

Brief summary

Cohort prospective study. Objectives : Primary objective: To describe the lung ultrasound lesions in pregnant women in case of suspected or confirmed COVID-19 Secondary objectives: * To compare the lung ultrasound lesions with chest Computed Tomography -scanner (CT-Scan) lesions * To evaluate the performances of the lung ultrasound to diagnose COVID-19 in pregnant women * To evaluate predictive value of different lung ultrasound lesions for intensive care unit admission of pregnant women with suspected or confirmed COVID-19 * To describe the pregnancy issues of the study population Course of the study: * Inclusion of pregnant suspected of having COVID-19 and cared following the service protocol * Performing of lung ultrasound at bedside in labor ward or in COVID unit Primary outcome: Lung ultrasound lesions (and corresponding score) at the moment of the initial management of pregnant women suspected or confirmed with COVID-19 (having a nasopharyngeal Reverse Transcription Polymerase Chain Reaction (RT-PCR) SARS-CoV-2 and a chest CT-scan)

Interventions

DEVICEPerforming of lung ultrasound

Performing of lung ultrasound at bedside in labor ward or in COVID unit

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age greater than or equal to 18 years * Gestational age greater than or equal to 22 weeks of gestation * Pregnant women suspected of COVID-19 : * already having a nasopharyngeal RT-PCR for the SARS-CoV-2 * AND having a chest CT-scan or waiting for this exam * Women giving a writing consent to participate

Exclusion criteria

* Women giving an opposition to participate * Women not enough fluent in French to benefit from clear and intelligible information

Design outcomes

Primary

Measure	Time frame	Description
Description of the lesions	4 months	Description of the lesions in each of the 6 pulmonary quadrants on the right and left. Establishment of the ultrasound score corresponding to the sum of the scores attributed to each type of lesion in each quadrant (0: normal, 1: spaced comet tails, 2: curtain comet tails, 3: consolidation).

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026